Summary
Autoradiographic study of (14C-methyl)-L-methionine with brain tumor bearing rats aimed at an elucidation of the mechanism of tracer accumulation in the protein synthesis of tumor. Twice as much tracer accumulated in the tumors compared as in the contralateral gray matter (nontumor region) at 90 min post intravenous injection. The protein-bound fraction of the tumors, expressed as acid-insoluble fraction (AIF), was 1.7 ± 0.6 (mean ± standard deviation, n=6), significantly higher than that (0.8 ± 0.2) of the nontumor region (p<0.05 by the Mann-Whitney test). The tumor AIF comprised 82.3 ± 9.2% of the total amount of the tracers accumulated in the tumors. The protein synthesis inhibitor cycloheximide reduced the tracer uptake and the AIF of the tumors to an almost same level as the nontumor region. These findings indicate that metabolic acceleration of protein synthesis may be a main reason for the high accumulation of (14C-methyl)-L-methionine in tumor.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
DiChiro G, DeLaPaz RL, Brooks RA, Sokoloff L, Kornblith PL, Smith BH, Patronas NJ, Kufta CV, Kesseler RM, Johnston GS, Manning RG, Wolf AP: Glucose utilization of cerebral gliomas measured by [18F]fluorodeoxyglucose and positron emission tomography. Neurology 32:1323–1329, 1982
Patronas NJ, DiChiro G, Kufta C, Bairamian D, Kornblith PL, Simon R, Larson SM: Prediction of survival in glioma patients by means of positron emission tomography. J Neurosurg 62: 816–822, 1985
Derlon JM, Bourdet C, Bustany P, Chatel M, Theron J, Darcel F, Syrota A: [11C]L-Methionine uptake in gliomas. Neurosurgery 25: 720–728, 1989
Mineura K, Sasajima T, Kowada M, Shishido F, Uemura K: Changes in the (11C-methyl)-L-methionine uptake index in gliomas following radiotherapy. Jpn J Cander Clin 35:1101–1104, 1989 (in Japanese)
Mineura K, Sasajima T, Suda Y, Kowada M, Shishido F, Uemura K: Amino acid study of cerebral gliomas using positron emission tomography: Analysis of (11C-methyl)-Lmethionine uptake index. Neurol Med Chir (Tokyo) 30: 997–1002, 1990
Mineura K, Sasajima T, Suda Y, Kowada M, Shishido F, Uemura K: Early and accurate detection of primary cerebral glioma with mterfibrillary growth using11C-L-methionine positron emission tomography. J Med Imag 3:192–196, 1989
Mosskin M, Ericson K, Hindmarsh T, von Holst H, Collins VP, Bregstrom M, Eriksson L, Johnstrom P: Positron emission tomography compared with magnetic resonance imaging and computed tomography in supratentorial gliomas using multiple stereotactic biopsies as reference. Acta Radiol 30:225–232, 1989
Mineura K, Sasajima T, Kowada M, Uesaka Y, Shishido F: Innovative approach in the diagnosis of gliomatosis cerebri using11C-L-methionine positron emission tomography. J Nucl Med 32:726–728, 1991
Lilja A, Bergstrom K, Hartvig P, Spannarew B, Halldin C, Lundqvist H, Langstrom B: Dynamic study of supratentorial gliomas with L-methyl-11C-methionine and positron emission tomography. AJNR 6: 505–514, 1985
Bergstrom M, Ericson K, Hagenfeldt L, Mosskin M, von Holst H, Noren G, Eriksson L, Ehrin E, Johnstrom P: PET study of methionine accumulation in glioma and normal brain tissue: Competition with branched chain amino acids. J Comput Assist Tomogr 11: 208–213, 1987
Marrian DH, Maxwell DR: Tracer studies of potential radiosensitizing agents. Tetrasodium 2-14C-methyl-1:4-naphthohydroquinone diphosphate. Br J Cancer 10: 575–582, 1956
Abe Y, Matsuzawa T, Ito M, Ishiwata K, Fujiwara T, Sato T, Yamaguchi K, Ido T: Regional coupling of blood flow and methionine uptake in an experimental tumor assessed with autoradiography. Eur J Nuci Med 14: 388–392, 1988
Dwyer BE, Donatoni P, Wasterlain CG: A quantitative autoradiographic method for the measurement of local rates of brain protein synthesis. Neurochem Res 7: 563–576, 1982
Zar JH: Biostatistical Analysis. Prentice-Hall Inc, Englewood Cliffs, 1984, pp 138–145
Oldendorf WH: Brain uptake of radiolabeled amino acids, amines, and hexoses after arterial injection. Am J Physiol 221:1629–1639, 1971
Bustany P. Henry JF, de Rotrou J, Signoret P, Cabanis E, Zarifian E, Ziegler M, Derlon JM, Crouzel C, Soussaline F, Comar D: Correlations between clinical state and positron emission tomography measurement of local brain protein synthesis in Alzheimer's dementia, Parkinson's disease, schizophrenia, and gliomas. In: Greitz T,et al. (eds) The Metabolism of the Human Brain Studied with Positron Emission Tomography. Raven Press, New York, 1985, pp 241–249
Jones RM, Cramer S, Sargent T, Budinger TF: Brain protein synthesis rates measuredin vivo using methionine and leucine. J Nucl Med 26: 830, 1985
Phelps ME, Barrio JR, Huang SC, Keen RE, Chugani H, Mazziotta JC: Criteria for the tracer kinetic measurement of cerebral protein synthesis in humans with positron emission tomography. Ann Neurol 15 (suppl): S192–202, 1984
Ishiwata K, Vaalburg W, Elsinga PH, Paans AMJ, Woldring MG: Comparison of L-[1-11C]methionine and L-methyl-[11C]methionine for measuringin vivo protein synthesis rates with PET. J Nucl Med 29:1419–1427, 1988
Shishido F, Murakami M, Miura S, Takahashi K, Inugami A, Tomura N, Higano S, Fujita H, Kanno I, Sasaki H, Iida H, Mineura K, Uemura K: Clinical investigation of18F-fluorophenylalanine for brain tumor imaging. Comparison with11Cmethionine. Jpn J Nucl Med 25:1431–1435, 1988 (in Japanese)
Jimenez A: Inhibitors of translation. Trends Biochem Sci 1: 28–30, 1976
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Mineura, K., Sasajima, T., Kuwahara, N. et al. (14C-Methyl)-L-methionine uptake in rat brain tumors before and after treatment with the protein synthesis inhibitor cycloheximide. J Neuro-Oncol 15, 229–233 (1993). https://doi.org/10.1007/BF01050068
Issue Date:
DOI: https://doi.org/10.1007/BF01050068